Name rings no bells, but OK--long time no chat. mesaone was not a boiler room agent, while cappy indeed ever so was hooked to houses, insiders and cronies doing one thing or another.
So: $4000, into around 100,000,000. Same as 4 into 100. Now, multiply by 4, and add in the filed data about the bekakda way BTX has always recorded Hextend revs.
Now--adjust for the reality that the Hextend patents are near expiry. And that in about 2010 the 10K said BTX was abandoning any and all R&D along those lines, which dooms the other "fluid" patents (There's around 10, dealing with dextrose)
Then the reality check--burn rate--can take center stage.
Then note that AK put the beginnings of a death spiral into the last tranche, and that burn + death spiral says that around the end of 2016 there will be another serious round of dilution, with no off-setting revs.
Nope. Hestend sales would support a price around 1/8. --- $0.125 for the newbies. The patent estate supports around 1 1/2.
So anything over 1.62 is, for the time being, the corspicle cult and hype.
(In a "bear mkt" for bio-bull, that patent estate drops to under 1 buck.)
"Not many shares to go around when this gets rolling." Lots of shares to get dumped onto the mkt any time BTX sees AST as overpriced---which will be constant process for years to some.
" Are any of these stem cell stock a home run waiting to happen?"
NO. Period. But they are all hyped in rotation as being the Next Big Thing, with BTX serving as the sinking mother ship of them all. After thorough DD, any of them them can be played cyclically, as rollers, and traded into accumulation.
Until it has operational revs - COG above G&A, it's going to keep trending (with hype fueled beta) towards 2-3X book--which according to BTX itself would be under 1 !/2. Hype can support 5X book---around 2.
The burn rate ensures Dilution, which will ensure oversupply of stock to the prudent mkt.
Hype will ensure occasional spikes to be fed to retail road kill.
Those dog&pony shows are for moving shelf stock, and mooving T-stock off the shelf at Garfies and AK.
Since BTX looks like it will need another major round of dilution around year's end, it is of course starting now at making its principle product since 1992, hype.
"But I like this company. Just trying not to be emotional about it." And so back to what vi have been saying here, If you like this dawg trade into accumulation til you've got a basis like insiders and cronies--which is well under $2. Far under $2.
noach, Yeah. Don;t pay more than $2.35.... Let the road kill do the rest.
AK also knows what he's doing--keep those free shares of his from hitting the mkt. Let Neal (who is relatively young) keep them out of circulation.
So evidently at this point Neal doesn't want to pay more than $2.35. So why should anyone else want to pay more?
So they can be members of the road kill club?
Especially when they are invented by boiler room touts.
Other targets, like 5x book, do seem to be getting met. On this dawg that's ~$2
" That's NOT how to make money in the market (and they know it)." Right. That's done by finding companies with a plausible route to cash flow positive. BTX is not now, nor has it been since 2002, such a company.
According to its own filings its on the way to a death spiral debenture.........again.
They're not all fat. Just failed at anything except dumping T-stock onto retail road kill. BTw, have you been following the BTX vs. ^rut 5 year? The rain may be coming......
Charlantans? From the Italian, " ciarlatano "a quack," from ciarlare "to prate, babble," from ciarla "chat, prattle," perhaps imitative of ducks' quacking."
THat is, if it walks like a loser, and quacks like a birdbrain, it's a dog, to be played with by specialists and MMs.
Thumbs up for another artiucle on how irrelevant BTX is becoming, and the real revenue streams.
WTs are intended to look like freebies to retail. The issue is, like most "free" things, they are worthless unless some event happens--like, in this case, BTX trading well above the strike price of the WTs.
When, as almost always happens on an already publicly traded stock, the underlying stays below the strike, they expire worthless.
BTX has a history of repricing warrants much cheaper for the benefit of insiders and cronies, to trade more T-stock for cash. Since BTX went public in 92 with 3mm shares, T-stock has been its major product.
"Of course it went down. " The "short squeeze" is over, and the "longs" and the professional shorts picked up another crop of retail road kill.
Noach, See how easy that was? Ignore all of the "long" rats' droppings and smoke&mirrors. Do the actual DD, read the filings, read the chart. Ignore any and all nonsense about "stem cells" or "Mikey" --or at least learn what the heck this stuff is about-- and, if you like this dog, trade into accumulation.
O-- and get over any of your idiocy about "shorts" and blahblah....